Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.

P.W. Collins; S. Björkman; K. Fischer; V. Blanchette; M. Oh; P. Schroth; S. Fritsch; K. Casey; G. Spotts; B.M. Ewenstein

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.

Translated title of the contribution: Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.

P.W. Collins
, S. Björkman
, K. Fischer
, V. Blanchette
, M. Oh
, P. Schroth
, S. Fritsch
, K. Casey
, G. Spotts
, B.M. Ewenstein

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.
Original language	Undefined/Unknown
Pages (from-to)	269-275
Number of pages	7
Journal	Journal of Thrombosis and Haemostasis
Volume	8
Issue number	2
Publication status	Published - 2010

Cite this

Collins, P. W., Björkman, S., Fischer, K., Blanchette, V., Oh, M., Schroth, P., Fritsch, S., Casey, K., Spotts, G., & Ewenstein, B. M. (2010). Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. Journal of Thrombosis and Haemostasis, 8(2), 269-275.

@article{2d907d0860c14d7a9cdedc30bcff309f,

title = "Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.",

author = "P.W. Collins and S. Bj{\"o}rkman and K. Fischer and V. Blanchette and M. Oh and P. Schroth and S. Fritsch and K. Casey and G. Spotts and B.M. Ewenstein",

year = "2010",

language = "Undefined/Unknown",

volume = "8",

pages = "269--275",

journal = "Journal of Thrombosis and Haemostasis",

issn = "1538-7933",

publisher = "Elsevier",

number = "2",

}

Collins, PW, Björkman, S, Fischer, K, Blanchette, V, Oh, M, Schroth, P, Fritsch, S, Casey, K, Spotts, G & Ewenstein, BM 2010, 'Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.', Journal of Thrombosis and Haemostasis, vol. 8, no. 2, pp. 269-275.

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. / Collins, P.W.; Björkman, S.; Fischer, K. et al.
In: Journal of Thrombosis and Haemostasis, Vol. 8, No. 2, 2010, p. 269-275.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.

AU - Collins, P.W.

AU - Björkman, S.

AU - Fischer, K.

AU - Blanchette, V.

AU - Oh, M.

AU - Schroth, P.

AU - Fritsch, S.

AU - Casey, K.

AU - Spotts, G.

AU - Ewenstein, B.M.

PY - 2010

Y1 - 2010

M3 - Article

SN - 1538-7933

VL - 8

SP - 269

EP - 275

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

IS - 2

ER -